Neus Basté
Impact in
- Otorhinolaryngology top 2%
- Head and Neck Cancer Studies
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Cancer Diagnosis and Treatment
Papers in
-
- Head and Neck Cancer Studies 18
- Oncology 16
- Cancer Immunotherapy and Biomarkers 10
- Lung Cancer Research Studies 7
- Cancer Diagnosis and Treatment 5
- Co-authors
- Richard Greil (6 shared papers)Brett Hughes (6 shared papers)Barbara Burtness (6 shared papers)Kevin J. Harrington (6 shared papers)Thorsten Fuereder (6 shared papers)Makoto Tahara (6 shared papers)Danny Rischin (6 shared papers)Amanda Psyrri (7 shared papers)
- Journals
- Journal of Clinical Oncology (10 papers)Annals of Oncology (4 papers)Oral Oncology (2 papers)Current Opinion in Oncology (2 papers)Clinical & Translational Oncology (2 papers)
- Partner nations
- SpainUnited StatesUnited Kingdom
In The Last Decade
Neus Basté
30 papers receiving 451 citations
Neus Basté's Hit Papers
Peers
Comparison fields: 5 of 53
- Otorhinolaryngology 180
- Oncology 207
- Cancer Research 45
- Immunology 61
- Pulmonary and Respiratory Medicine 80
Countries citing papers authored by Neus Basté
This map shows the geographic impact of Neus Basté's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neus Basté with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neus Basté more than expected).
Fields of papers citing papers by Neus Basté
This network shows the impact of papers produced by Neus Basté. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neus Basté. The network helps show where Neus Basté may publish in the future.
Co-authors
The 25 scholars most cited alongside Neus Basté, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pembrolizumab alone or with chemotherapy for recurrent/metastatic head and neck squamous cell carcinoma in KEYNOTE-048: subgroup analysis by Programmed Death Ligand-1 combined positive score Hit paper breakdown → | 2022 | 115 |
| 2 | 2019 | 101 | |
| 3 | 2018 | 32 | |
| 4 | 2017 | 22 | |
| 5 | 2021 | 22 | |
| 6 | 2021 | 17 | |
| 7 | 2018 | 17 | |
| 8 | 2020 | 16 | |
| 9 | 2020 | 12 | |
| 10 | 2020 | 12 | |
| 11 | 2021 | 10 | |
| 12 | 2019 | 9 | |
| 13 | 2020 | 8 | |
| 14 | 2020 | 7 | |
| 15 | 2021 | 7 | |
| 16 | 2019 | 7 | |
| 17 | 2021 | 6 | |
| 18 | 2021 | 5 | |
| 19 | 2022 | 5 | |
| 20 | 2022 | 4 |
About Neus Basté
Neus Basté is a scholar working on Otorhinolaryngology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Surgery, having authored 33 papers that have together received 457 indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (18 papers), Cancer Immunotherapy and Biomarkers (10 papers), Lung Cancer Research Studies (7 papers), Cancer Diagnosis and Treatment (5 papers), Cancer Genomics and Diagnostics (4 papers), Thyroid Cancer Diagnosis and Treatment (3 papers), Lung Cancer Treatments and Mutations (3 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Otorhinolaryngology (180 citations), Oncology (207 citations), Cancer Research (45 citations), Immunology (61 citations) and Pulmonary and Respiratory Medicine (80 citations). Neus Basté has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Richard Greil, Brett Hughes, Barbara Burtness, Kevin J. Harrington, Thorsten Fuereder, Makoto Tahara, Danny Rischin, Amanda Psyrri, Nuttapong Ngamphaiboon and Denis Soulières. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Oral Oncology, Current Opinion in Oncology and Clinical & Translational Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.